SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-341091
Filing Date
2018-12-03
Accepted
2018-12-03 16:06:00
Documents
5
Period of Report
2018-12-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d655035d8k.htm 8-K 16645
2 EX-99.1 d655035dex991.htm EX-99.1 23880
3 EX-99.2 d655035dex992.htm EX-99.2 51975
4 GRAPHIC g655035004.jpg GRAPHIC 11115
5 GRAPHIC g655035g1130232502679.jpg GRAPHIC 3606
  Complete submission text file 0001193125-18-341091.txt   108780
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 181214068
SIC: 2834 Pharmaceutical Preparations